[1]刘佳*,蔡小凤.白细胞介素-17基因启动子区域甲基化与宫颈癌的关系研究[J].中国计划生育和妇产科,2017,(12):64- 66,70.
　LIU Jia*,CAI Xiao-feng.Study on relationship of promoter region methylation of IL-17 gene andcervical cancer[J].Chinese Journal of Family Planning & Gynecotokology,2017,(12):64- 66,70.
点击复制

白细胞介素-17基因启动子区域甲基化与宫颈癌的关系研究
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2017年12期
页码:
64- 66,70
栏目:
论著与临床
出版日期:
2017-12-25

文章信息/Info

Title:
Study on relationship of promoter region methylation of IL-17 gene and cervical cancer
作者:
刘佳*; 蔡小凤
黄石市中医医院妇科
Author(s):
LIU Jia*;  CAI Xiao-feng
Department of Gynecology, Huangshi Chinese Medicine Hospital, Huangshi Hubei 435000,P.R.China
关键词:
宫颈癌; IL-17基因; 甲基化修饰
Keywords:
cervical cancer;  IL-17 gene;  methylation
分类号:
R 71174
摘要:
目的检测宫颈癌白细胞介素17（interleukin-17,IL-17）基因启动子区域甲基化的变化，探讨其相关的临床意义。方法选取2015年2月至2017年3月黄石市中医医院妇产科收治的宫颈癌患者手术切除的宫颈癌组织87例为宫颈癌组，选取同期因功血、子宫肌腺病等子宫良性病变切除的正常宫颈组织40 例为对照组。IL-17基因启动子甲基化使用亚硫酸盐修饰后聚合酶链式反应检测。结果87例宫颈癌组织标本中检测到IL-17基因启动子甲基化阳性率为172 %，显著低于对照组的425 %（P<005）。IL-17基因启动子甲基化阳性率在宫颈癌患者不同年龄和组织类型之间差异无统计学意义（P>005）。但IL-17基因启动子甲基化阳性率在FIGO临床分期Ⅲ、Ⅳ期患者为109 %，显著低于Ⅰ、Ⅱ期患者的244 %（P<005）。IL-17基因启动子甲基化阳性率在有淋巴结转移患者为122 %，显著低于无淋巴结转移患者的237 %（P<005）。IL-17基因启动子甲基化阳性率在中、低分化患者为125 %，显著低于高分化患者的258 %（P<005）。结论IL-17基因启动子在宫颈癌组织中呈现低甲基化状态，与宫颈癌的临床分期、有无淋巴结转移以及肿瘤分化程度密切相关。
Abstract:
ObjectiveTo detect promoter region methylation of interleukin-17(IL-17) gene in cervical cancer and explore its clinical significance. Methods87 cervical cancer tissue resected in surgery from patients with cervical cancer in Huangshi Chinese Medicine Hospital from February 2015 to March 2017 were selected.40 normal cervical tissue resected from patients with dysfunctional uterine bleeding, uterine adenomyosis and other benign uterine lesions were selected as control. IL-17 gene promoter methylation was detected using a sulfite modified polymerase chain reaction assay. ResultsThe positive rate of IL-17 gene promoter methylation in cervical cancer patients was 172%, which was significantly lower than that of 425% in control group(P<005). There was no significant difference of positive rate of IL-17 gene promoter methylation between different ages and tissue type in cervical cancer(P>005).The positive rate of IL-17 methylation in Ⅲ and Ⅳ stage cervical cancer group was 109%, which was lower than that of 244% in Ⅰ and Ⅱ stage cervical cancer group(P<005). The positive rate of IL-17 methylation in lymph node metastasis group was 122%, which was lower than that of 237% in non-lymph node metastasis group(P<005). The positive rate of IL-17 methylation in median and low differentiation group was 125%, which was lower than that of 258% in well differentiation group group(P<005). ConclusionLower-methylation of IL-17 was detected in cervical cancer，which was related to clinical stages, lymph node metastasis and tumor differentiation of cervical cancer.

参考文献/References:

［1］陈万青，郑荣寿，张思维，等．2012年中国恶性肿瘤发病和死亡分析 ［J］．中国肿瘤，2016，25（1）：1-8． ［2］徐浩, 吴淋淋, 袁青. Th 17、Th 22、Treg细胞及相关细胞因子在宫颈癌患者外周血中变化及意义 ［J］. 中国卫生检验杂志, 2017, 27(2):217-219，222. ［3］Souza JM, Matias BF, Rodrigues CM, et al. IL-17 and IL-22 serum cytokine levels in patients with squamous intraepithelial lesion and invasive cervical carcinoma ［J］. Eur J Gynaecol Oncol, 2013, 34(5): 466-468. ［4］宋利．宫颈癌患者血清中IL-17水平的检测及临床意义 ［J］．现代预防医学，2012，39（19）：4966-4967, 4976． ［5］CONG Jianglin, LIU Riming, WANG Xuan, et al. Association between interluekin-17 gene polymorphisms and the risk of cervical cancer in a Chinese population ［J］. Int J Clin Exp Pathol, 2015, 8(8): 9567-9573. ［6］赵子龙，周国江，任玉峰，等．IL-1β、IL-6、IL-17的表达和HPV感染与宫颈癌的相关性研究 ［J］．实用癌症杂志，2017，32（3）：358-360． ［7］薛纪森，陈骋，朱华，等．IL-17在高危型HPV阳性宫颈癌中的表达 ［J］．温州医科大学学报，2016，46（1）：24-27, 32． ［8］战祥波，宫凤艳，杨丽丽，等．IL-17单核苷酸多态性与宫颈癌的相关性研究 ［J］．中国妇幼保健，2016，31（20）：4117-4118． ［9］袁陆，张丽杰，李鸥，等．白介素17基因启动子区 CpG 岛甲基化与宫颈癌的相关性研究 ［J］．中国全科医学，2016，19（27）：3300-3305． ［10］LI L, TIAN Y-l, LV X-m, et al. Association analysis of IL-17A and IL-17F polymorphisms in Chinese women with cervical cancer ［J］. Genet Mol Res, 2015, 14(4): 12178-12183. ［11］张丽丽，沈婕，邓蓉蓉，等．IL-17和IL-17受体及其基因多态性的研究进展 ［J］．医学综述，2014，20 （13）：2344-2346．

相似文献/References:

[1]冯学宇,乔银川,王好宁,等.823例宫颈癌机会性筛查结果分析[J].中国计划生育和妇产科,2010,(01):0.
　FENG Xue-yu,QIAO Yin-chuan,WANG Hao-ning ..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(12):0.
[2]刘佳汭.保留盆腔自主神经的宫颈癌根治性手术[J].中国计划生育和妇产科,2010,(02):0.
[3]甘玉杰,熊小英,蔡春芳,等.血清SCCA、CA125、CA19-9与高危型人乳头状瘤病毒在宫颈癌及癌前病变中的表达及意义[J].中国计划生育和妇产科,2010,(04):0.
　GAN Yu-jie,XIONG Xiao-ying,CAI Chun-fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(12):0.
[4]肖春燕,陈桂珍,铁木帅龙,等.325例宫颈病变阴道镜检查结果分析[J].中国计划生育和妇产科,2010,(05):0.
　XIAO Chun-yan,CHEN Gui-zhen,TIEMU-Shuailong.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(12):0.
[5]钟茜,赵霞.宫颈癌诊治中的过度治疗与治疗不足[J].中国计划生育和妇产科,2013,(02):0.
　ZHONG Xi,ZHAO Xia,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[6]安红梅,张雯,邓继红,等.昆明地区高危HPV病毒载量与宫颈病变和宫颈癌相关性[J].中国计划生育和妇产科,2013,(03):0.
　AN Hong - mei,ZHANG Wen,DENG Ji - hong *,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[7]闵爱萍,谢桂清,冷开容,等.Hepsin、Maspin在宫颈疾病中的表达及其临床意义[J].中国计划生育和妇产科,2013,(06):0.
　Min Ai-ping,Xie Gui-qing,Leng Kai-rong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[8]朱书力,李力.树突状细胞对宫颈癌作用的研究进展[J].中国计划生育和妇产科,2014,(03):0.
[9]闵爱萍.刺猬蛋白在宫颈癌组织中的表达及其临床意义[J].中国计划生育和妇产科,2014,(07):0.
　MIN Ai-ping,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(12):0.
[10]孙肖霞,王志莲,郝敏,等.胰岛素样生长因子轴与宫颈癌的相关性研究[J].中国计划生育和妇产科,2015,(05):0.

更新日期/Last Update: 2017-12-25